Search company, investor...

Founded Year

2017

Stage

Series B | Alive

Total Raised

$80.5M

Last Raised

$40M | 3 yrs ago

About Datavant

Datavant is dedicated to accelerating the discovery, development, and commercialization of new medicines through machine learning. It aims to partner with biomedical research institutions to eliminate silos of information and unlock insights from healthcare data. The firm was founded in 2017 and is based in San Francisco, California.

Headquarters Location

2 Embarcadero Center 7th Floor

San Francisco, California, 94111,

United States

+1 415 525 1171

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

ESPs containing Datavant

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Drug R&D Tech

The EHR-based patient recruitment market focuses on utilizing electronic health record (EHR) data to identify and recruit eligible patients for clinical trials. This market offers a range of solutions that enable efficient and targeted patient recruitment based on factors such as medical history, demographics, and clinical characteristics. By using EHR-based patient recruitment solutions, research…

Datavant named as Leader among 8 other companies, including Paradigm, Verana Health, and TriNetX.

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Expert Collections containing Datavant

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Datavant is included in 4 Expert Collections, including Artificial Intelligence.

A

Artificial Intelligence

10,944 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

C

Conference Exhibitors

5,302 items

D

Digital Health

10,565 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

P

Precision Medicine Tech Market Map

160 items

This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.

Datavant Patents

Datavant has filed 9 patents.

The 3 most popular patent topics include:

  • Data management
  • Information privacy
  • Privacy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/25/2021

9/12/2023

Grant

Application Date

6/25/2021

Grant Date

9/12/2023

Title

Related Topics

Status

Grant

Latest Datavant News

New Mountain runs single-asset process on Datavant

Sep 20, 2023

Sources point to an influx of deals hitting the market toward the end of summer that may drive volume, especially as pricing has improved. Email address I accept: Email address A link has been emailed to you - check your inbox. Sign in to your account Email address Nearly there! A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@peimedia.com . Copyright PEI Media Share with other subscribers Cancel

Datavant Frequently Asked Questions (FAQ)

  • When was Datavant founded?

    Datavant was founded in 2017.

  • Where is Datavant's headquarters?

    Datavant's headquarters is located at 2 Embarcadero Center, San Francisco.

  • What is Datavant's latest funding round?

    Datavant's latest funding round is Series B.

  • How much did Datavant raise?

    Datavant raised a total of $80.5M.

  • Who are the investors of Datavant?

    Investors of Datavant include Roivant Sciences, Transformation Capital, Johnson & Johnson Innovation, Cigna Ventures, Flex Capital and 5 more.

  • Who are Datavant's competitors?

    Competitors of Datavant include Briya and 4 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Datavant to Competitors

Medable Logo
Medable

Medable operates as a global platform for decentralized clinical trials. It solves the systemic challenges inherent in modern clinical trials including access, interoperability between systems, and inefficient technology experiences. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

ConcertAI Logo
ConcertAI

ConcertAI is a healthcare technology company. It uses artificial intelligence (AI) to help oncologists make more informed treatment decisions for their patients. The platform analyzes large datasets of clinical and genomic data to identify patterns and insights which is used for personalized cancer treatment. It was formerly known as Precision HealthAI. It was founded in 2017 and is based in Cambridge, Massachusetts.

Tempus Logo
Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility. The company enables physicians to deliver personalized cancer care for patients through analytical and machine-learning platforms. It provides genomic sequencing services and molecular therapeutic data analysis to empower physicians to make real-time, data-driven decisions. It serves clients in the healthcare sector. It was formerly known as Tempus Consulting. The company was founded in 2015 and is based in Chicago, Illinois.

Owkin Logo
Owkin

Owkin specializes in developing artificial intelligence (AI) technologies for clinical research and developing drugs and treatments for patients. It empowers researchers in hospitals, universities, and the biopharmaceutical industry to understand drug efficacy varies, improves the drug development process, and help identify key drugs and treatments for individual patients to improve patient outcomes. The company was founded in 2016 and is based in New York, New York.

e
ePHealth

ePHealth offers a mobile-first end-to-end decentralized clinical trial platform. The platform integrates patients, recruiting sites and coordinating centers. The features of the platform include trial management, trial conduct and patient enrollment. It was founded in 2015 and is based in London, United Kingdom.

nference Logo
nference

nference makes biomedical knowledge computable to solve urgent healthcare problems of biopharmas and medical centers. The company offers EMR data, software products and services, record de-identification, curation of unstructured information, and data creation via digitization of pathology and molecular sequencing. It was founded in 2013 and is based in Cambridge, Massachusetts.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.